Market Updates

Green Initiatives in Healthcare
February, 2019

GREEN INITIATIVESIt is clear that there is a global imperative for the healthcare industry to find solutions to some of the negative effects medical waste is imposing on the environment. Hence, the healthcare leaders as well as many emerging organizations are working to pioneer the industry into a more sustainable green machine. Few of the recent examples are cited as following: Siemens, whose businesses range from power plants to medical imaging machines, [...]

Read More

$100m Worth Deal with Meiragtx to Enhance the J&J Gene Therapy Unit
February, 2019

Janssen Pharmaceutical Companies of Johnson & Johnson has taken a giant leap into gene therapy, with a collaboration deal with UK based biotech company MeiraGTx. The company is also concentrating on working on gene therapies for salivary gland problems and neurodegenerative diseases.The deal includes licensing of two inherited retinal disorder candidate for a value of $100m, and is proffering nearly $340m additional payments on progress towards market. The returns of this deal include the global rights of the gene th [...]

Read More

Future of Remote Monitoring Devices
February, 2019

Real-time and remote patient monitoring devices have changed the face of healthcare increasingly. Today getting preventive care outside hospital setting has become seamless and may startups, have developed products and services that have revolutionized the medical care by streamlining the costs. Remote patient monitoring devices are evolving in the healthcare sector and has spread widely across the medical field. Importance of remote patient monitoring devices has played a vital role in onsite hospitals, clinics, at home clinics, and remote are [...]

Read More

World’s First Total Body Scanner has the Potential to Revolutionize Medical Imaging
February, 2019

The world's first medical imaging scanner EXPLORER, that can capture a 3-D picture of the whole human body has produced its first scans few months back. Developed by UC Davis scientists Simon Cherry and Ramsey Badawi, EXPLORER is a combination PET and X-ray computed tomography scanner that can image the entire body. This machine captures radiation far more efficiently than other scanners and can produce an image in one second and, over time it can produce movies that can track specially tagged drugs as they move inside the entire body. This tec [...]

Read More

3D-Printed Surgery Stents for Easy Closure of Arteries
February, 2019

A new 3D printed stent is developed by the Scientists at the University of Nebraska-Lincoln, which can help the cardiologists in suturing the small arteries. It is 3D-printed with a sugar-based substance, which melts and dissolves in minutes subsequent to the closure of the artery.Currently, one of the major challenges faced by the specialist is joining the open end of arteries. Nevertheless, the technique is dynamic in a range of surgical procedure, such as transplantation of organ or reconstructive surgeries. It is well-kn [...]

Read More

Transformation in Prosthetic Care
February, 2019

Delivery of prosthetic enhancement is improving the lives of many people by providing quality life to more amputees. There are exciting new technologies that give promising solutions. The next generation ankle systems for amputees have shown excellent improvements in providing power, stability, quality, control, and battery run time (optional). One such is the BIONX empower ankle. These systems have integrated battery design that feels less bulky and greater power delivery. The new techniques have revolutionized the provision of prosthetic care [...]

Read More

Pfizer Makes Significant Gains In Oncology Portfolio With CHMP nod To Approve Vizimpro In Europe
February, 2019

Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has given a positive opinion for the approval of Vizimpro (dacomitinib) developed by Pfizer, Inc. for the treatment of lung cancer. Pfizer is eyeing approval of Vizimpro (45 mg) in Europe for the first-line treatment of metastatic non-small cell lung cancer (NSCLC) in patients with EGFR activating mutations.  The drug was approved in the US in September 2018. The drug holds immense sales potential as EGFR-mutated non-NSCLC is associated with low ov [...]

Read More

2018, Year of Healthcare Product Recalls
February, 2019

2018 had been the year of significant product recalls by major healthcare manufacturers. Starting from healthcare giants such as GE Healthcare, Medtronic, and Abbott Laboratories, the industry faced debacles in the continuation of branded medical devices by the consumers. Medtronic itself witnessed at least three different product recalls in 2018, impacting its Cardiovascular business globally. On the other hand, GE Healthcare confronted at least two product recalls in the last year.Provided are the most significant product [...]

Read More

Rising Focus on Advanced Machine Condition Monitoring Solutions in Manufacturing Sector
February, 2019

Industrial Internet of things (IIOT) solutions are transforming the manufacturing sector in terms of operational efficiency. Globally, manufacturers are focusing on incorporating IoT-enabled solutions to improve production efficiency. Traditional conditional monitoring practices involves capturing measurements in a standardised repetitive process by taking measurements of key head components one by one, which costs companies time, money, and the acquired data is prone to errors. Hence companies have started focusing on deploying IoT empowered s [...]

Read More

Hitachi Chemical to Acquire Biopharma
February, 2019

Hitachi announced about the agreement where apceth Biopharma GmbH will join the Hitachi Chemical’s PCT services.  The firm manufactures gene and cell therapy products. America and Europe are its major market. The firm has 2 manufacturing units in Munich, Germany. As per this agreement Hitachi will acquire manufacturing units and some area of cleanroom.The coming together of both firms will strengthen their global market presence and help them to be the second largest in their of  gene and cell therapy market. [...]

Read More